Biocon Intrinsic Value
Biocon (BIOCON) median intrinsic value is ₹447.55 from 8 valuation models (range ₹126–₹839), vs current price ₹421.10 — +6.3% upside (Trading Near Calculated Value), margin of safety 5.9%. Browse BIOCON balance sheet details for revenue, profit, balance sheet and cash flow data.
BIOCON Valuation Methods Summary — DCF, Graham Number & P/E
Biocon intrinsic value across 8 models vs current price ₹421.10 — upside/downside and value range per method. For current market price and key ratios, visit BIOCON share price.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹126.33 | ₹101.06 - ₹151.60 | -70.0% | EPS: ₹3.16, Sector P/E: 22x |
| Book Value Method | asset | ₹839.26 | ₹755.33 - ₹923.19 | +99.3% | Book Value/Share: ₹419.63, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹447.55 | ₹402.80 - ₹492.31 | +6.3% | Revenue/Share: ₹223.77, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹473.49 | ₹426.14 - ₹520.84 | +12.4% | EBITDA: ₹3840.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹680.17 | ₹544.14 - ₹816.20 | +61.5% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹126.33 | ₹113.70 - ₹138.96 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹126.33 | ₹113.70 - ₹138.96 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| Graham Defensive Method | conservative | ₹172.73 | ₹155.46 - ₹190.00 | -59.0% | EPS: ₹3.16, BVPS: ₹419.63 |
BIOCON Intrinsic Value vs Market Price — All Valuation Models
Biocon fair value range ₹126–₹839 vs current market price ₹421.10 across 8 valuation models. Also explore BIOCON price trends to track price trends across different timeframes.
BIOCON Intrinsic Value Analysis — Undervalued or Overvalued?
Biocon median intrinsic value ₹447.55, current price ₹421.10 — Trading Near Calculated Value by 6.3%, margin of safety 5.9%.
What is the intrinsic value of BIOCON?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Biocon (BIOCON) is ₹447.55 (median value). With the current market price of ₹421.10, this represents a +6.3% variance from our estimated fair value.
The valuation range spans from ₹126.33 to ₹839.26, indicating ₹126.33 - ₹839.26.
Is BIOCON undervalued or overvalued?
Based on our multi-method analysis, Biocon (BIOCON) appears to be trading near calculated value by approximately 6.3%.
BIOCON Financial Health — Key Ratios vs Industry Benchmarks
Biocon financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.33 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 2.3% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 20.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.29x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
BIOCON Cash Flow Quality — Operating & Free Cash Flow
Biocon operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹4,061 Cr | ₹3,960 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹2,954 Cr | ₹2,453 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹1,853 Cr | ₹-5,277 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹1,177 Cr | ₹346 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹1,160 Cr | ₹-666 Cr | Positive Operating Cash Flow | 6/10 |